These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11888633)

  • 1. Fusidic acid resistance in Staphylococcus aureus isolates.
    Brown EM; Thomas P
    Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
    [No Abstract]   [Full Text] [Related]  

  • 2. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
    Mason BW; Howard AJ; Magee JT
    J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
    Mason BW; Howard AJ
    Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
    Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to fusidic acid.
    Turnidge J; Collignon P
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S35-44. PubMed ID: 10528785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid.
    Tünger O; Arisoy A; Kurutepe S; Akçali S; Ozbakkaloğlu B
    Int J Antimicrob Agents; 2001 Nov; 18(5):445-7. PubMed ID: 11711260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA; Mascini EM; Blok HE; Sanders CJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Fucidin.
    Dealler S; Fraser AK
    J R Coll Gen Pract; 1986 Mar; 36(284):136. PubMed ID: 3712354
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
    Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
    Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efforts to support the development of fusidic acid in the United States.
    Fernandes P; Pereira D
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
    El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
    J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
    Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
    den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
    Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.